13F-HR filed by BVF INC/IL
BVF INC/IL filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 62 holding rows worth $3,637,401,571.
- Accession
- 0000921895-24-001219
- Filer
- CIK 1056807
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 62 entries on the cover page, a total value of $3,637,401,571 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,637,401,571 with VALUE read as dollars as filed, 13F file number 028-06800. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerBVF PARTNERS L P/IL028-06770
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 21,751,284 | $1,092,566,995 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 5,161,801 | $207,504,400 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 5,981,212 | $192,774,463 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 3,922,413 | $124,968,078 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 10,400,158 | $110,865,684 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 2,919,818 | $109,931,148 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 4,370,024 | $109,775,003 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 3,755,990 | $108,660,791 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 2,428,613 | $105,280,374 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 9,135,893 | $103,418,309 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 4,786,293 | $102,091,630 | dollars as filed | |
| XOMA ROYALTY CORPORATION | 98419J206 | COMMON STOCK | 3,633,743 | $87,391,519 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 1,884,191 | $82,715,985 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 4,661,194 | $76,443,582 | dollars as filed | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 8,748,629 | $74,275,860 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 5,870,000 | $61,752,400 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 1,863,809 | $60,014,650 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 3,196,701 | $54,471,785 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 1,172,249 | $52,786,372 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 1,162,306 | $51,001,987 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 7,000,000 | $50,190,000 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 10,333,600 | $48,671,256 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 4,047,354 | $47,111,201 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,875,000 | $44,625,000 | dollars as filed | |
| AC IMMUNE SA | H00263105 | SHS | 14,571,236 | $43,130,859 | dollars as filed | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 4,365,933 | $41,214,408 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M105 | COM | 2,251,037 | $38,155,077 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 1,521,948 | $35,994,070 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 812,988 | $34,844,666 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 2,742,409 | $28,904,991 | dollars as filed | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 9,544,262 | $28,632,786 | dollars as filed | |
| Tscan Therapeutics Inc | 89854M101 | COM | 2,989,474 | $23,736,424 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 16,552,417 | $20,856,045 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 1,685,219 | $19,885,584 | dollars as filed | |
| CALLIDITAS THERAPEUTICS AB SPONSERED | 13124Q106 | ADS | 750,000 | $16,237,500 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 6,595,801 | $14,378,846 | dollars as filed | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 2,312,200 | $11,861,586 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 3,853,818 | $11,754,145 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 8,902,972 | $11,751,923 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 2,000,000 | $10,560,000 | dollars as filed | |
| ELEDON PHARMACEUTICALS INC | 28617k101 | COM | 4,326,710 | $8,913,023 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 650,000 | $8,632,000 | dollars as filed | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 4,769,164 | $6,772,213 | dollars as filed | |
| CIDARA THERAPEUTICS INC COM NEW | 171757107 | Stock | 6,861,127 | $6,312,237 | dollars as filed | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 1,813,633 | $6,184,489 | dollars as filed | |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 1,202,067 | $5,733,860 | dollars as filed | |
| UNICYCIVE THERAPEUTICS INC | 90466Y103 | CMN | 3,611,601 | $4,984,009 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M113 | W EXP 10/31/2028 | 945,402 | $4,916,090 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 917,826 | $4,166,930 | dollars as filed | |
| LEXICON PHARMACEUTICALS INC | 528872302 | COMMON STOCK | 1,686,924 | $4,048,618 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 1,239,470 | $4,028,278 | dollars as filed | |
| KRONOS BIO INC | 50107A104 | COM | 2,905,043 | $3,776,556 | dollars as filed | |
| PIERIS PHARMACEUTICALS INC | 720795103 | COM | 20,609,863 | $3,775,727 | dollars as filed | |
| VIRACTA THERAPEUTICS INC | 92765F108 | COM | 3,614,662 | $3,686,955 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 686,040 | $2,483,465 | dollars as filed | |
| FORTE BIOSCIENCES INC | 34962G109 | COM | 2,982,105 | $2,089,561 | dollars as filed | |
| MOLECULAR PARTNERS AG | 60853G106 | ADS | 443,221 | $1,719,697 | dollars as filed | |
| MOLECULAR TEMPLATES INC | 608550208 | COM | 522,238 | $1,169,813 | dollars as filed | |
| NLS PHARMACEUTICS LTD COM NEW | H57830103 | Stock | 5,747,126 | $1,044,828 | dollars as filed | |
| ASLAN PHARMACEUTICALS LTD | 04522R200 | SPON ADS NEW | 1,049,999 | $645,959 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 361,406 | $643,303 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 190,815 | $486,578 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000921895-24-001219 | this filing | 2024-05-15 | acceptance time not in the bulk data set |